Listing 1 - 2 of 2 |
Sort by
|
Choose an application
This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision support, and the incorporation of PGx into clinical care.
Medicine --- Pharmacology --- pharmacogenomics --- return of results --- genetic counseling --- qualitative --- pharmacogenetics --- implementation --- pharmacogenetics service --- screening --- pre-emptive --- personalized medicine --- precision medicine --- community pharmacy --- pharmacogenomic testing --- genetic privacy --- pharmaco-economics --- polymorphisms --- pharmacogenes --- pharmacogenomic --- machine learning --- adaptation --- human evolution --- US Food and Drug Administration --- clinical actionability --- clinical translation --- chronic kidney disease --- CYP3A5 --- polymorphism --- progression --- pharmacogenomics (PGx) --- pediatrics --- best practice alerts (BPAs) --- electronic health records (EHR) --- genomic indicators --- clinical decision support (CDS) --- phenotype --- genotype --- polypharmacy --- chronic disease --- medication management --- electronic medical record --- artificial intelligence --- n/a
Choose an application
This colligated Special Issue of Pharmaceutics on Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy offers to the reader a series of articles that describe the concept of Precision Medicine, discuss its implementation process and limitations, demonstrate its value by illustrating some clinical cases, and open the door to new and more sophisticated techniques and applications.
Medicine --- Clinical & internal medicine --- fibromyalgia (FM) --- myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) --- microRNA --- miRNome --- pharmacogenomics --- pharmacoepigenomics --- SM2miR --- Pharmaco-miR --- repoDB --- ME/CFS Common Data Elements (CDEs) --- dihydropyrimidine dehydrogenase --- DPYD --- 5-fluorouracil --- fluoropyrimidine --- therapeutic drug monitoring --- orthotopic liver transplant --- busulfan --- glutathione S-transferase --- genetic polymorphism --- limited sampling strategy --- pharmacokinetics --- clinical pharmacogenetics --- pharmacogenetic testing --- adverse drug reactions --- genotype --- phenotype --- pharmacogene --- barriers to pharmacogenetics implementation --- Sub-Saharan Africa --- chronic low back pain (cLBP) --- genetics --- personalized treatment --- polymorphism --- CYP450 --- tacrolimus --- CYP3A5 --- liver transplant --- pharmacogenomic --- minority --- data collection --- drug --- biomarker --- pharmacogenetics --- pharmacogenetic test --- personalized medicine --- gene expression --- infliximab --- adalimumab --- ulcerative colitis --- Crohn disease --- inflammatory bowel disease --- n/a
Listing 1 - 2 of 2 |
Sort by
|